E Fund Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$436K Buy
+20,796
New +$468K 0.01% 313
2025
Q2
$329K Buy
9,052
+752
+9% +$27.1K 0.02% 286
2025
Q1
$301K Buy
8,300
+1,100
+15% +$45.8K 0.01% 313
2024
Q4
$303K Buy
7,200
+877
+14% +$43.5K 0.02% 313
2024
Q3
$351K Sell
6,323
-1,339
-17% -$68.2K 0.02% 235
2024
Q2
$315K Sell
7,662
-915
-11% -$39.1K 0.02% 224
2024
Q1
$400K Sell
8,577
-3,294
-28% -$155K 0.02% 221
2023
Q4
$568K Buy
11,871
+2,467
+26% +$95.6K 0.04% 134
2023
Q3
$335K Buy
9,404
+711
+8% +$28.2K 0.03% 198
2023
Q2
$401K Sell
8,693
-1,271
-13% -$59K 0.03% 166
2023
Q1
$400K Sell
9,964
-434
-4% -$18.6K 0.03% 166
2022
Q4
$482K Buy
10,398
+725
+7% +$28.5K 0.04% 133
2022
Q3
$401K Buy
9,673
+894
+10% +$45.9K 0.04% 184
2022
Q2
$524K Buy
8,779
+4,678
+114% +$288K 0.05% 136
2022
Q1
$298K Buy
+4,101
New +$285K 0.01% 199

Other funds holding RARE